» Articles » PMID: 26795065

Development and Preliminary Data on the Use of a Mobile App Specifically Designed to Increase Community Awareness of Invasive Pneumococcal Disease and Its Prevention

Abstract

Given the growing use and great potential of mobile apps, this project aimed to develop and implement a user-friendly app to increase laypeople's knowledge and awareness of invasive pneumococcal disease (IPD). Despite the heavy burden of IPD, the documented low awareness of IPD among both laypeople and healthcare professionals and far from optimal pneumococcal vaccination coverage, no app specifically targeting IPD has been developed so far. The app was designed to be maximally functional and conceived in accordance with user-centered design. Its content, layout and usability were discussed and formally tested during several workshops that involved the principal stakeholders, including experts in IPD and information technology and potential end-users. Following several workshops, it was decided that, in order to make the app more interactive, its core should be a personal "checker" of the risk of contracting IPD and a user-friendly risk-communication strategy. The checker was populated with risk factors identified through both Italian and international official guidelines. Formal evaluation of the app revealed its good readability and usability properties. A sister web site with the same content was created to achieve higher population exposure. Seven months after being launched in a price- and registration-free modality, the app, named "Pneumo Rischio," averaged 20.9 new users/day and 1.3 sessions/user. The first in-field results suggest that "Pneumo Rischio" is a promising tool for increasing the population's awareness of IPD and its prevention through a user-friendly risk checker.

Citing Articles

[ (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].

Boccalini S, Panatto D, Mennini F, Marcellusi A, Bini C, Amicizia D J Prev Med Hyg. 2021; 62(1 Suppl 1):E1-E128.

PMID: 34622076 PMC: 8452280. DOI: 10.15167/2421-4248/jpmh2021.62.1s1.


The Experience of VaccinarSinToscana Website and the Role of New Media in Promoting Vaccination.

Boccalini S, Bonanni P, Chiesi F, Di Pisa G, Furlan F, Giammarco B Vaccines (Basel). 2020; 8(4).

PMID: 33153005 PMC: 7712014. DOI: 10.3390/vaccines8040644.


Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.

Boccalini S, Zanella B, Landa P, Amicizia D, Bechini A, Innocenti M Microorganisms. 2020; 8(11).

PMID: 33138142 PMC: 7692044. DOI: 10.3390/microorganisms8111681.


[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].

Boccalini S, Bechini A, Sartor G, Paolini D, Innocenti M, Bonanni P J Prev Med Hyg. 2020; 60(3 Suppl 2):E1-E94.

PMID: 32047867 PMC: 7007189. DOI: 10.15167/2421-4248/jpmh2019.60.3s2.


Creating a Theoretically Grounded, Gamified Health App: Lessons From Developing the Cigbreak Smoking Cessation Mobile Phone Game.

Edwards E, Caton H, Lumsden J, Rivas C, Steed L, Pirunsarn Y JMIR Serious Games. 2018; 6(4):e10252.

PMID: 30497994 PMC: 6293248. DOI: 10.2196/10252.


References
1.
Bish A, Yardley L, Nicoll A, Michie S . Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine. 2011; 29(38):6472-84. DOI: 10.1016/j.vaccine.2011.06.107. View

2.
Lode H, Ludwig E, Kassianos G . Pneumococcal infection--low awareness as a potential barrier to vaccination: results of a European study. Adv Ther. 2013; 30(4):387-405. DOI: 10.1007/s12325-013-0025-4. View

3.
Schneeberg A, Bettinger J, McNeil S, Ward B, Dionne M, Cooper C . Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 2014; 14:442. PMC: 4046143. DOI: 10.1186/1471-2458-14-442. View

4.
Theidel U, Kuhlmann A, Braem A . Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals. Dtsch Arztebl Int. 2013; 110(44):743-50. PMC: 3831240. DOI: 10.3238/arztebl.2013.0743. View

5.
Brewer N, Chapman G, Gibbons F, Gerrard M, McCaul K, Weinstein N . Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007; 26(2):136-45. DOI: 10.1037/0278-6133.26.2.136. View